Federal and state actions seek transparency and fair reimbursements from pharmacy benefit managers, as rural communities lose local drugstores.

The Consolidated Appropriations Act of 2026 acts as a first step in addressing prescription drug pricing challenges related to the role of pharmacy benefit managers (PBMs).

The Consolidated Appropriations Act of 2026 and the Department of Labor’s proposed rule implement major PBM reforms for employers, but don’t include everything they want, including a ban on spread ...

The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen. The ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. On the heels of the FTC’s investigation into pharmacy ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Policy proposals targeting pharmacy benefit managers are reshaping how prescription drug ...